Skip to main content

Table 1 CMR endpoints day 3 post-PPCI

From: Erythropoietin doubles the incidence of microvascular obstruction in primary PCI - a randomized controlled trial in acute MI using CMR primary endpoints

Endpoint Placebo Erythropoietin P value
LVEF 53 ± 11% 51 ± 7% P = 0.26
24 hr AUC Trop-T 101.7 ± 67.5 μg/l 114.6 ± 78.3 μg/l P = 0.56
24 hr AUC CK-MB 3512 ± 2692 μg/l 4682 ± 2946 μg/l P = 0.15
LGE/AAR 67.8 ± 2.0% 71.5 ± 17.0% P = 0.58
Myocardial salvage index 0.36 ± 0.23 0.29 ± 0.17 P = 0.28
MVO (incidence) 42% 82% P = 0.008*
LVEDVi 73 ± 13 ml/m2 84 ± 10 ml/m2 P = 0.003*
LVESVi 34 ± 11 ml/m2 41 ± 9 ml/m2 P = 0.035*